Article info
PDFHealth economics
Research
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective
- Correspondence to Dr Christine G Kohn; Christine.kohn{at}hhchealth.org
Citation
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective
Publication history
- Received May 21, 2015
- Revised September 21, 2015
- Accepted October 12, 2015
- First published November 6, 2015.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/